Bioceres Crop Solutions Reports Margin Expansion and Improved Profitability in Q1 FY2026

Key Takeaways

• Bioceres Crop Solutions (NASDAQ: BIOX) reported revenues of $77.5 million for Q1 FY2026, down 17% year-over-year, reflecting a planned transition away from low-margin and working-capital-intensive sales.
• Gross profit reached $36.2 million with margins improving to 47%, up from 40% in the prior-year quarter, driven by a more profitable product mix.
• Operating profit increased 200% to $7.1 million, while Adjusted EBITDA rose 61% to $13.6 million, highlighting strong cost control and operational efficiency.
• Seed and Integrated Products revenue declined 37% as the company continues restructuring its seed business model; Crop Protection and Crop Nutrition sales decreased 16% and 2%, respectively.
• CEO Federico Trucco reaffirmed focus on profitability, cost discipline, and capital structure optimization, positioning Bioceres for long-term resilience amid gradual market normalization in Argentina.

Bioceres Delivers Improved Margins Despite Lower Revenue in First Quarter FY2026

Bioceres Crop Solutions Corp. (NASDAQ: BIOX), a global agricultural biotechnology company focused on regenerative and climate-resilient farming, announced financial results for the fiscal first quarter ended September 30, 2025. While total revenue declined as anticipated, profitability and efficiency metrics strengthened significantly, marking progress in the company’s ongoing strategic reset.

Total revenue came in at $77.5 million, down 17% year-over-year, primarily due to the planned reduction of low-margin and working-capital-intensive sales and the continued transition of the seed model. Despite this, gross margin expanded to 47% from 40%, reflecting a stronger product mix and operational streamlining.

“This quarter reflects clear progress on the priorities we set for the year: improve the quality of revenues, protect margins, and operate with discipline,” said Federico Trucco, CEO of Bioceres Crop Solutions. “Profitability improved and costs continued to decrease as we reduced exposure to low-margin activities and focused on a more efficient product mix.”

Segment Performance: Crop Protection and Seeds Under Strategic Transition

By segment, Crop Protection contributed $39.9 million, down 16% year-over-year, largely due to the timing of sales in key Latin American markets such as Uruguay. Seed and Integrated Products generated $12.6 million, down 37%, reflecting the company’s shift away from less profitable channels and inventory-heavy operations. Crop Nutrition remained relatively stable, down just 2% at $25.1 million.

Despite lower revenues, operational profitability improved. Operating profit rose 200% year-over-year to $7.1 million, supported by reduced SG&A expenses and structural cost savings. Adjusted EBITDA increased 61% to $13.6 million, demonstrating the success of Bioceres’ margin-focused approach.

Financial Overview: Margin Expansion and Cost Discipline Drive Performance

Bioceres reported a gross profit of $36.2 million, down 3% from the prior year but accompanied by a 651-basis-point improvement in gross margin. The company achieved this through product mix optimization and efficiency gains in operating expenses.

Net loss widened slightly to $7.5 million (from $6.2 million in Q1 FY2025), as higher financing costs and increased tax accruals offset operational gains. Working capital, however, continued to improve year-over-year, reflecting stronger inventory and receivables management.

“Argentina remains challenging, although conditions are showing early signs of normalization,” Trucco noted. “We will continue to focus on fundamentals we control — margin quality, cost discipline, and working-capital efficiency — while positioning the company for long-term resilience.”

Bioceres Strategic Outlook: Strengthening Profitability and Financial Flexibility

Looking ahead, Bioceres plans to maintain its focus on high-margin products, operating efficiency, and capital structure optimization. The company’s approach includes continued cost rationalization and efforts to increase financial flexibility in a gradually improving macroeconomic environment.

The strategic pruning of low-return business segments and the strengthening of its seed, biological, and crop nutrition portfolios are expected to support sustained profitability growth.

With Adjusted EBITDA up 61% year-over-year and gross margins nearing 50%, Bioceres enters FY2026 with a stronger foundation for long-term growth in its mission to regenerate agricultural ecosystems and enhance climate resilience.

Read the complete financial results.